Last Updated : April 5, 2023
CADTH is inviting stakeholder feedback on a proposal to introduce time-limited reimbursement recommendations. These are recommendations that would be issued in favour of reimbursement in a manner that is time-limited and contingent upon a future reassessment of additional evidence that addresses the uncertainty with the comparative clinical benefit and cost-effectiveness for the drug or drug regimen under review.
Complete details of the proposed procedures, along with a summary document, are provided in CADTH Consultation: Proposed Process for Time-limited Reimbursement Recommendations.
To provide comments on the proposal, please use the feedback template. Feedback must be received by CADTH by 5:00 p.m. ET on May 1, 2023. For feedback to be considered, you must identify yourself to CADTH. Only 1 response per organization will be considered. If you have any questions about the feedback process, please email email@example.com.